QA: Rezolute Inc. in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001509261_2017_Rezolute_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001509261')"}

Graph

Absolute values for 0001509261, Rezolute Inc.

  xvar xval
0 AssetsCurrent 4,492,107
1 IntangibleAssetsNetIncludingGoodwill 51,614
2 PropertyPlantAndEquipmentNet 5,984,670
3 remainder_Assets 375,000
4 LiabilitiesCurrent 1,730,500
5 LiabilitiesNoncurrent 400,038
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,502,902
9 ResearchAndDevelopmentExpense 9,448,388
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 15,748
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 10,903,391
1 Liabilities 2,130,538
2 Expenses 14,951,290
3 Revenues 0
4 StockholdersEquity 8,772,853
5 NetIncome -14,935,542
6 ComprehensiveNetIncome -14,935,542
7 BaseVar 14,000,484
8 EconomicCapitalRatio 0.0236

Edgar->Model Mapping

Feature Distribution